Issues related to pharmaceutical manufacuring. Drug pricing. Trade and tariffs.; Issues related to pharmaceutical manufacuring. Drug pricing. Trade and tariffs.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:73dff0d9-7042-4636-8fea-54f90781ad75
Registrant ID:401105121
Client ID:71418
2026-02-24
MARSHALL & POPP, LLC
DAIICHI SANKYO, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical manufacturing and drug pricing. Issues related to trade and tariffs.; Issues related to pharmaceutical manufacturing and drug pricing. Issues related to trade and tariffs.
Registered Lobbyists (2)
HAZEN MARSHALL ●NEW— Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don NicklesMONICA POPP ●NEW— Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
IDs
Filing UUID:0dde4e28-b044-496a-89f0-bb48708af48c
Registrant ID:401105121
Client ID:71431
2026-02-19
CONTINENTAL STRATEGY, LLC
IMMIX BIOPHARMA, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to the FDA
Registered Lobbyists (2)
LUKE NICKLESS ●NEW— Senior Policy Advisor, Appropriations, House Committee on the BudgetTIMOTHY COSTA ●NEW— Chief of Staff to Dan Meuser
IDs
Filing UUID:03c76883-a9f0-4ac8-a7dc-d60387645b34
Registrant ID:401106285
Client ID:71337
2026-02-19
K&L GATES, LLP
BORYUNG CORPORATION
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Pharmaceutical and life sciences research in space.; Pharmaceutical and life sciences research in space.; Pharmaceutical and life sciences research in space.
Registered Lobbyists (2)
MICHAEL HEARD SNOW ●NEW— Extern, House Select Cmte on Climate CrisisVARUN JAIN ●NEW— Dep GC, USDOT; Sr. Counselor to OIRA Admin, OMB; Asst GC, OMB; Econ & Legal Fellow, Sen. Whitehouse
IDs
Filing UUID:35b5c741-ffe0-43cd-966f-d9399f24a670
Registrant ID:32098
Client ID:71342
2026-02-18
W STRATEGIES, LLC
BRISTOL-MYERS SQUIBB COMPANY
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Education about the value of biopharmaceutical innovation and related issues.
Registered Lobbyists (1)
DARREN WILLCOX ●NEW— Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director
IDs
Filing UUID:4665d562-d7d6-4324-8a6a-6c0e6a8c7581
Registrant ID:400605842
Client ID:71322
2026-02-18
CAPITOL COUNSEL LLC
MADRIGAL PHARMACEUTICALS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
FDA and regulatory issues related to the biopharmaceutical industry.; FDA and regulatory issues related to the biopharmaceutical industry.; FDA and regulatory issues related to the biopharmaceutical industry.
Registered Lobbyists (7)
ANN JABLON ●NEW— Chief of Staff, Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal.CHARLES MICHAELS ●NEW— Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.GEORGE SIFAKIS ●NEW— Assistant to the President of the United States and Director of the Office of Public Liaison (President Trump, 2017).JEFFREY CARROLL ●NEW— Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone.JOHN MARTIN ●NEW— Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.LYNDON BOOZER ●NEWSHANNON FINLEY ●NEW
IDs
Filing UUID:66453105-53de-4d9f-b8b3-a837e3cc00eb
Registrant ID:313715
Client ID:71323
2026-02-13
CROSSROADS STRATEGIES, LLC
ALKERMES, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Policiesimpacting pharmaceutical development, patient access, drug pricing, and supply chain.
Registered Lobbyists (4)
CHERYL JAEGER ●NEW— Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. CoxJASON VAN PELT ●NEW— Legislative Director, Senior Legislative Asst, Legislative Asst, Staff Asst: Rep. Ed WhitfieldMATHEW LAPINSKI ●NEWSTEPHEN VOLJAVEC ●NEW— Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn
IDs
Filing UUID:bfb856dc-4047-4b07-83f6-65c561fe6983
Registrant ID:400531586
Client ID:192194
2026-02-13
MONUMENT ADVOCACY
CENCORA
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
Registered Lobbyists (2)
COLTON HENNING ●NEWJOEL WHITE ●NEW— Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays
IDs
Filing UUID:6de75cc0-14cc-4d64-8db0-d32ddde1f3b0
Registrant ID:308775
Client ID:71234
2026-02-11
SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA
COLLEGIUM PHARMACEUTICAL, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
U.S. Executive Branch engagement
Registered Lobbyists (4)
CHRISTIAN BOURGE ●NEWNICHOLAS VANDER POEL ●NEWROBERT STRYK ●NEWTIMOTHY CURRY ●NEW
IDs
Filing UUID:3255e75a-038b-4cc2-9d8f-1ad9142bd188
Registrant ID:298158
Client ID:71155
2026-02-11
VENABLE LLP
STRIVE SPECIALTIES, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Issues related to pharmaceutical industry oversight
Registered Lobbyists (5)
DEAN HELLER ●NEW— US Senator; US House RepresentativeDEEPTI LOHARIKAR ●NEWJOHN V. DRZEWICKI ●NEW— Staff Assistant, Rep. Steve Austria; Policy Advisor, US House of Representatives; Policy Director, House Republican ConferenceJOSH FINESTONE ●NEW— Legislative Assistant, Rep. Mike Rogers; Legislative Director, Rep. Tom Graves; Legislative Assistant, Sen. Dean Heller; Senior Legislative Assistant, Sen. Dean Heller; Professional Staff, Senate Committee on Commerce, Science and TransportationLAURA HANEN ●NEW
IDs
Filing UUID:224727a2-5152-4fa1-930b-6ab0b0f2e614
Registrant ID:39941
Client ID:71157
2026-02-02
MR. BRIAN KELLY
TAKEDA PHARMACEUTICAL COMPANY
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
IDs
Filing UUID:17f82d66-4228-4427-b5ec-1319ee55a8bf
Registrant ID:40024191
Client ID:64735
2026-01-30
LANTHEUS HOLDINGS, INC.
LANTHEUS HOLDINGS, INC.
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Medicare payment for radiopharmaceuticals Advanced diagnostic access; Medicare payment for radiopharmaceuticals Advanced diagnostic access; Medicare payment for radiopharmaceuticals Advanced diagnostic access
Issues related to coverage of pharmaceutical products
Registered Lobbyists (1)
DANA SINGISER ●NEW— Issues regarding contraceptive healthcare campaign and Right to Contraception Act
IDs
Filing UUID:e6572de7-410b-49cf-b2b2-f01f5524a5f9
Registrant ID:401110199
Client ID:70591
2026-01-12
BGR GOVERNMENT AFFAIRS
PFIZER, INC
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
Specific Issues
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally and/or Pfizer specifically.
Government Entities
Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (9)
BRENT DEL MONTE — Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce CommitteeCHRIS KELLY — Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. BlackburnDANIEL FARMER — Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack SpaceJOEL BAILEY — COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. RahallJOHN STONE — Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CMARVIN FIGUEROA — COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White HouseRAGHAV AGGARWAL — Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of InteriorREMY MASON — Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzROBERT WOOD — Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
IDs
Filing UUID:2db1d393-b505-448f-89b1-89597eb5cacf
Registrant ID:5357
Client ID:106343
2026-01-12
BGR GOVERNMENT AFFAIRS
NEUROCRINE BIOSCIENCES, INC.
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
Specific Issues
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy
Government Entities
Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (9)
BRENT DEL MONTE — Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce CommitteeDANIEL FARMER — Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack SpaceJOEL BAILEY — COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. RahallJOHN STONE — Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CMARVIN FIGUEROA — COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White HouseRAGHAV AGGARWAL — Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of InteriorREMY MASON — Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzROBB WALTON — Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. NunesROBERT WOOD — Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
IDs
Filing UUID:97f53de5-92ac-485e-8e52-75320aeafe00
Registrant ID:5357
Client ID:106706
2026-01-12
BGR GOVERNMENT AFFAIRS
WALGREEN CO.
$0
$0
Filing Details
Type: ld2 • Year: 2026 Q1
Specific Issues
Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry
Government Entities
Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (9)
BRENT DEL MONTE — Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce CommitteeCHRIS KELLY — Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. BlackburnDANIEL FARMER — Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack SpaceJOEL BAILEY — COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. RahallJOHN STONE — Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CMARVIN FIGUEROA ●NEW— COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White HouseRAGHAV AGGARWAL — Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of InteriorREMY MASON — Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzROBB WALTON — Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
IDs
Filing UUID:9b25d84e-e453-45cb-a198-0491ca121cd7
Registrant ID:5357
Client ID:106757
2026-01-08
FORWARD GLOBAL
FARUK CAPAN ON BEHALF OF IT'S ALL GOOD, LLC
$0
$0
Filing Details
Type: ld1 • Year: 2026 Q1
Specific Issues
Drug pricing reform, pharmaceutical advertising, use of AI in healthcare.
Registered Lobbyists (4)
AVA COFIELL ●NEWLIZZY IRWIN ●NEWNICK BONFIGLIO ●NEWTHOMAS MATHIASEN ●NEW
IDs
Filing UUID:53bc64e9-bb5f-48e4-b87b-c172d0e7c271
Registrant ID:401105597
Client ID:70452
2026-01-06
VENABLE LLP
AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS
$30,000
$0
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
Increasing access to mental health and substance use treatment, including via telehealth; Mental health & substance use disorder workforce; Federal funding for mental health and substance use programs, research and training; Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; H.R. 2483, Reauthorization of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act; H.R. 2509/S. 931, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act; Transparency and streamline utilization management protocols including prior authorization and step therapy (H.R. 8702/S. 4532); Preventing and reducing suicide; Medicare Part B coverage of pharmacist provided patient care services; Occupational Therapy Mental Health Parity Act (H.R. 4037/S. 2847).
DOUGLAS HUYNHKEATON HIGGINS ●NEWMICHAEL BAXTER ●NEW
IDs
Filing UUID:4d31eee0-6423-40e8-9da7-4e5abff32881
Registrant ID:3071
Client ID:103628
2026-01-06
AMERICAN COLLEGE OF CLINICAL PHARMACY
AMERICAN COLLEGE OF CLINICAL PHARMACY
$0
$144,981
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.; Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D.; Promote greater medication safety and more appropriate medication use through more active involvement of pharmacists in patient care.; Seek restoration of Medicare funding for specialized residency training under Medicare prospective payment rules. Seek pharmacist participation in National Health Service Corps (NHSC) loan repayment programs. Support development of inter-professional health education programs by working with Congress to make programs authorized under Title VII of the Public Health Service Act a significant aspect of comprehensive health professions education.; Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
Registered Lobbyists (2)
JOHN MCGLEW — Senior Director, Government AffairsKATHERINE PHAM — Senior Director, Policy and Professional Affairs
IDs
Filing UUID:fdc9720a-30cd-4f38-b544-e86228eaa7d1
Registrant ID:57258
Client ID:159980
2026-01-05
CORNERSTONE GOVERNMENT AFFAIRS, INC.
ABBVIE INC.
$60,000
$0
Filing Details
Type: ld2 • Year: 2025 Q4
Specific Issues
International tax issues and pharmaceutical pricing and access issues, and patent issues.; International tax issues and pharmaceutical pricing and access issues, and patent issues.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (5)
JOHN CRUMBLISSJOHN SANDELL — Tax Counsel, Legislative Assistant; Ways and Means Committee (Camp, Ryan, Brady)MICHAEL GOODMAN — Chief of Staff House Member Office (Kind), Legislative Staff House Member Office (Braley, Barrow)STACY RICH — Leadership Staff Director, Senior Leadership Advisor and Floor Director, Leadership Advisor (Senate -Murray); Senate Cloakroom Asst, Dem Cloakroom (Reid, Daschle); Staff/Press Asst (Daschle)TODD WEBSTER — Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons)
Advocate on concerns relating to intrusion of government mandates into commercial insurance marketplace for pharmacy benefits managers; advocate concerns and proper consideration of Medicaid Part D provisions in legislative packages including proposed year-end ACA subsidy bill. Monitor relevant committee hearings on PBM legislation.